Your Article Summary
See Latest ArticlesDenosumab update
Current Opinion in Rheumatology, 06/11/09
Lewiecki EM - Denosumab is a promising therapeutic agent for the management of postmenopausal osteoporosis and rheumatoid arthritis.
Related Articles
Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
The Journal of Urology, 11/16/09
Relevance Score: 87%
A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09
Relevance Score: 83%
Bone health and prostate cancer
Prostate Cancer & Prostatic Diseases, 11/13/09
Relevance Score: 77%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site
Bone , 12/11/09
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: Systematic review and meta-analysis
Osteoporosis International, 12/10/09
The efficacy of calcitriol therapy in the management of bone loss and fractures: A qualitative review
Osteoporosis International, 12/10/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts
Rheumatology, 12/11/09
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: Systematic review and meta-analysis
Osteoporosis International, 12/10/09
The efficacy of calcitriol therapy in the management of bone loss and fractures: A qualitative review
Osteoporosis International, 12/10/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
A new graph and scoring system simplified analysis of changing states: disease remissions in a rheumatoid arthritis clinical trial
Journal of Clinical Epidemiology, 12/11/09
Criterion Contamination of Depression Scales in Patients with Rheumatoid Arthritis: The Need for Interpretation of Patient Questionnaires (as All Clinical Measures) in the Context of All Information About the Patient
Rheumatic Disease Clinics of North America, 12/11/09
RAPID3, an Index to Assess and Monitor Patients with Rheumatoid Arthritis, Without Formal Joint Counts: Similar Results to DAS28 and CDAI in Clinical Trials and Clinical Care
Rheumatic Disease Clinics of North America, 12/11/09